EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Disulfiram blocks inflammatory TLR4 signaling by targeting MD-2

Yang Bai, Rui Min, Pengcheng Chen, Shenglin Mei, Fan Deng, Zengzhang Zheng, Cong Jiang, Rui Miao, Zeyu Wu, Peng Zhang, Youdong Pan, Judy Lieberman iD und 1 weitere

Proceedings of the National Academy of Sciences · 2023-08 · 120 (31)

DOI: 10.1073/pnas.2306399120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 24.07.2023. Verfasst von Yang Bai und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy o…. Hauptthemen laut MEDLINE: Disulfiram, Alcoholism. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toll-like receptor 4 (TLR4) sensing of lipopolysaccharide (LPS), the most potent pathogen-associated molecular pattern of gram-negative bacteria, activates NF-κB and Irf3, which induces inflammatory cytokines and interferons that trigger an intense inflammatory response, which is critical for host defense but can also cause serious inflammatory pathology, including sepsis. Although TLR4 inhibition is an attractive therapeutic approach for suppressing overexuberant inflammatory signaling, previously identified TLR4 antagonists have not shown any clinical benefit. Here, we identify disulfiram (DSF), an FDA-approved drug for alcoholism, as a specific inhibitor of TLR4-mediated inflammatory signaling. TLR4 cell surface expression, LPS sensing, dimerization and signaling depend on TLR4 binding to MD-2. DSF and other cysteine-reactive drugs, previously shown to block LPS-triggered inflammatory cell death (pyroptosis), inhibit TLR4 signaling by covalently modifying Cys133 of MD-2, a key conserved residue that mediates TLR4 sensing and signaling. DSF blocks LPS-triggered inflammatory cytokine, chemokine, and interferon production by macrophages in vitro. In the aggressive N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease (PD) in which TLR4 plays an important role, DSF markedly suppresses neuroinflammation and dopaminergic neuron loss, and restores motor function. Our findings identify a role for DSF in curbing TLR4-mediated inflammation and suggest that DSF and other drugs that target MD-2 might be useful for treating PD and other diseases in which inflammation contributes importantly to pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DisulfiramAlcoholismAnimalsMiceToll-Like Receptor 4LipopolysaccharidesSignal TransductionCytokines

Stichwörter der Autor:innen

DSFMD-2Parkinson’s diseaseTLR4cysteine-reactive covalent inhibitor

Substanzen

DisulfiramToll-Like Receptor 4LipopolysaccharidesCytokines

Autor:innen und Institutionen

  • The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115.
  • Shanghai Huashen Institute of Microbes and Infections, Shanghai 200052, China.
  • Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
  • Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.

ORCID-Profile: Judy Lieberman, Xing Liu

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
  • HHS | NIH | National Cancer Institute
  • National Key R&D Program of China
  • Key Research Program of the Chinese Academy of Sciences
  • National Natural Science Foundation of China
  • Shanghai Pilot Program for Basic Research-Chinese Academy of Sciences, Shanghai Branch

Zitieren

APA

Bai, Y., Min, R., Chen, P., Mei, S., Deng, F., Zheng, Z., Jiang, C., Miao, R., Wu, Z., Zhang, P., Pan, Y., Lieberman, J., & Liu, X. (2023). Disulfiram blocks inflammatory TLR4 signaling by targeting MD-2. Proceedings of the National Academy of Sciences, 120(31). https://doi.org/10.1073/pnas.2306399120

Vancouver

Bai Y, Min R, Chen P, Mei S, Deng F, Zheng Z, et al. Disulfiram blocks inflammatory TLR4 signaling by targeting MD-2. Proceedings of the National Academy of Sciences. 2023;120(31). doi:10.1073/pnas.2306399120

BibTeX
@article{Bai2023,
  author = {Bai, Yang and Min, Rui and Chen, Pengcheng and Mei, Shenglin and Deng, Fan and Zheng, Zengzhang and Jiang, Cong and Miao, Rui and Wu, Zeyu and Zhang, Peng and Pan, Youdong and Lieberman, Judy and Liu, Xing},
  title = {Disulfiram blocks inflammatory TLR4 signaling by targeting MD-2},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {31},
  doi = {10.1073/pnas.2306399120}
}
Kostenlos starten →